Since the beginning of the pandemic, lawmakers have set in motion roughly 20 bills focused on rebuilding the prescription supply chain in the U.S. Some lawmakers are proposing that drugmakers be prohibited from sourcing any of their ingredients from China or mandate consumer warnings on medications manufactured there.
Washington journalists have speculated that a potential presidential executive order would require government agencies to purchase only pharmaceuticals produced in the U.S. This leaves drugmakers with the choice to reshape their supply chain or lose their Veterans Affairs contracts.
Supply chain experts told STAT that efforts to revamp the supply chain have significant potential to generate unintended outcomes, such as the exacerbation of drug shortages and skyrocketing of prescription prices.
More articles on pharmacy:
Walgreens president leaves to become CEO of Tennessee health and fitness company
Consumers still feel comfortable picking up prescriptions at pharmacies, survey says
WHO suspends hydroxychloroquine trial over safety concerns
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
